136 - Precision Pediatric ID: Targeting Treatment and Prevention Strategies for Challenging Pediatric Infections

Saturday, October 2, 2021

1:15 PM - 3:00 PM EDT

Moderator(s)

Hayley Gans, MD

Professor
Stanford Univ Med Ctr
Palo Alto, CA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rebecca Pellett Madan, MD, MS

Associate Professor
NYU Grossman School of Medicine
Brooklyn, NY, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

Daniel Dulek, MD

Assistant Professor of Pediatrics
Vanderbilt University Medical Center; Monroe Carell Jr. Children's Hospital

Eurofins-Viracor (Individual(s) Involved: Self): Grant/Research Support; Horizon Therapeutics (Individual(s) Involved: Self): Advisor or Review Panel member
Kevin Downes, MD

Assistant Professor of Pediatrics
Division of Infectious Diseases
Children's Hospital of Philadelphia
Philadelphia, PA, United States

Merck (Individual(s) Involved: Self): Grant/Research Support
Jennifer Goldman, MD, MS-CR

Associate Professor
Pediatrics
Children's Mercy Kansas City, UMKC
Kansas City, MO, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:

Hayley Gans, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Rebecca Pellett Madan, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Daniel Dulek, MD: Eurofins-Viracor (Individual(s) Involved: Self): Grant/Research Support; Horizon Therapeutics (Individual(s) Involved: Self): Advisor or Review Panel member

Kevin J. Downes, MD: Merck (Individual(s) Involved: Self): Grant/Research Support

Jennifer Goldman, MD, MS-CR: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit
ACPE Credits: ACPE 1.75 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss current immunologic strategies to improve prevention and treatment of viral infections in pediatric transplant recipients
review current biomarker and gene expression strategies to identify bacterial infections in critically ill pediatric patients
define current and emerging methods to optimize antimicrobial dosing and prevent adverse reactions

Presentations:

Immunologic Risk Prediction and Treatment of Viral Infections in Transplant Recipients
Speaker: Daniel Dulek, MD – Vanderbilt University Medical Center; Monroe Carell Jr. Children's Hospital at Vanderbilt
Point of Care Prediction in Pediatric Sepsis and Pneumonia – Beyond Procalcitonin
Speaker: Kevin J. Downes, MD – Children's Hospital of Philadelphia
Predicting and Preventing Antibiotic Adverse Drug Reactions
Speaker: Jennifer Goldman, MD, MS-CR – Children's Mercy Kansas City, UMKC